Insulin glargine mechanism of action pdf

In type 1 diabetes patients treated with iv insulin, consider the longer onset of action of toujeo before stopping iv insulin. Long acting insulin analogs insulin glargine, insulin detemir which have an onset of insulin effect in 1 122 hours. As with all insulin preparations, the time course of lantus action may. Toujeo is a brandname prescription medication thats used to treat type 1 and type 2 diabetes.

Tuberculin syringe is the potential for confusion of volume and units. Feb 21, 2016 this video explains the molecular mechanism of insulin. The arginine amino acids shift the isoelectric point from a ph of 5. U300 insulin glargine is a concentrated form of glargine insulin contains 300 unitsml instead of the 100 uml in lantus that. Lantus insulin glargine injection rdna origin is a recombinant human insulin analog indicated for oncedaily subcutaneous administration in the treatment of patients over 17 years of age with type 1 or type 2 diabetes mellitus who require basal longacting insulin for the. March 2007 rx only lantus insulin glargine rdna origin injection lantus must not be diluted or mixed with any other insulin or solution. Pharmacokinetics and pharmacodynamics of insulin glargine given. Lantus insulin glargine dose, indications, adverse. The onset of action of toujeo develops over 6 hours following an injection. Insulin glargine is a longacting insulin that starts to work several hours after injection and keeps working evenly for 24 hours insulin glargine is used to improve blood sugar control in people with diabetes. Lantus insulin glargine injection is supplied as a clear solution containing 100 units per ml u100 of insulin glargine and is available in. The mode of action of insulin glargine is similar to that of naturally occurring human insulin produced by the pancreatic beta cells but its action lasts for a longer duration of time.

Insulin glargine is a recombinant human insulin analogue that does provide 24hour duration of action in most, but not all, patients with t1dm. U300 insulin glargine is a concentrated form of glargine insulin contains 300 unitsml instead of the 100 uml in lantus that can be used. Insulin glargine works by replacing the insulin produced by the body, stops sugar production in liver and helps movement of sugar from the blood into other body. Solution should be clear and colorlesswithnoparticulatematter. In other respects, its mechanism of action is similar to that of human insulin, and on a molar basis its glucoselowering effects are similar to those of human insulin when given intravenously. Insulin glargine 300 uml in the management of diabetes.

Modify insulin regimens only under medical supervision. Insulin glargine is a recombinant human insulin analog that is a longacting up to 24hour duration of action, parenteral bloodglucoselowering agent. Lantus insulin glargine rdna origin injection is a sterile solution of insulin glargine for use as an injection. Webmd provides common contraindications for insulin glargine subcutaneous. Design of the novel protraction mechanism of insulin.

Also, insulin glargine lowers the blood glucose concentration by. Donotmixinsulinglarginewithanyotherinsulinorsolution,orusesyringescontaining any other medicinal product or residue. Toujeo vs lantus efficacy and safety insulin glargine. This video explains the molecular mechanism of insulin. Insulin from latin insula, island is a peptide hormone produced by beta cells of the pancreatic islets. Like other types of insulin, the primary action of insulin glargine is to regulate glucose metabolism 01. Insulin glargine is a recombinant human insulin analogue that does provide 24hour duration of action. Longacting insulin glargine is a soluble, clear insulin, with a ph of 4. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. The insulin effect plateaus over the next few hours and is followed by a relatively flat duration of action that lasts 1224 hours for insulin detemir and 24 hours for insulin glargine. Pharmacokinetics and pharmacodynamics of insulin anna. Insulin and its mechanism of action insulin and its mechanism of action ashmita chaudhuri b. Find out what health conditions may be a health risk when taken with insulin glargine subcutaneous.

It differs from human insulin in that the amino acid asparagine at position a21 is replaced by glycine, and two arginines are added to the carboxy cterminus of the b chain. Objective to compare pharmacokinetics pk and pharmacodynamics pd of insulin glargine in type 2 diabetes mellitus t2dm after evening versus morning administration. Insulin pharmacology, therapeutic regimens, and principles. Insulin glargine is a selfinjectable solution used to control high blood sugar hyperglycemia in people with type 1 and type 2 diabetes. With morning administration insulin activity is greater in the.

Toujeo contains the same active ingredient, insulin glargine, as lantus. Product monograph lantus insulin glargine injection. Insulin and its mechanism of action linkedin slideshare. You should use insulin glargine at the same time every day. Description lantus insulin glargine rdna origin injection is a sterile solution of insulin glargine for use as an injection. Pharmacology pharmacodynamics mechanism of action the primary activity of insulin, including insulin glargine, is regulation of glucose metabolism. Insulin glargine was given to female rats before mating, during mating, and throughout pregnancy at doses up to 0. Enhances transmembrane passage of glucose across cell membranes. Lantus, inninsulin glargine european medicines agency. Insulin pens and needles must never be shared between patients. Since the introduction of insulin analogs in 1996, insulin therapy options for type 1 and type 2 diabetics have expanded. Also, insulin glargine lowers the blood glucose concentration by stimulating glucose uptake especially by muscle and fat 01.

Pharmacokinetics and pharmacodynamics of insulin glargine. A recombinant human insulin analog with a long duration of action. Lantus insulin glargine dose, indications, adverse effects. The full glucose lowering effect may not be apparent for at least 5 days see dosage and administration 2. Mechanism of action of insulin linkedin slideshare. Insulin is a drug prescribed to treat type 1 and type 2 diabetes. Its available as the brandname drugs lantus, basaglar. Insulin detemir dehteemeer has a fatty acid side chain that enhances association to albumin. Insulin glargine lowers blood glucose by stimulating peripheral glucose uptake and inhibiting hepatic glucose production. Atkinson, in williams textbook of endocrinology thirteenth edition, 2016.

Feb 17, 2014 insulin and its mechanism of action insulin and its mechanism of action ashmita chaudhuri b. Monitor blood glucose in all patients treated with insulin. What are the various actions of insulin apart from transporting glucose. Insulin glargine thus simulates the basal production of insulin. Pharm, 4th year, 7th semester roll 27701910050 nshm college of pharmaceutical technology 2. Insulin pens and needles must never be shared between. Insulin glargine lantus is an injectable form of longlasting insulin that is prescribed to regulate blood sugar levels in individuals with type 1 and type 2 diabetes. Insulin glargine has two additional arginine residues two positive charges and one amino acid modification from asn to gly, as compared with insulin. Insulin is a peptide hormone, produced by beta cells of the pancreas, and is central to regulating carbohydrate and fat metabolism in the body. This dose reduction will lower the likelihood of hypoglycemia see warnings and precautions 5.

Drugs used in diabetes, insulins and analogues for injection, longacting. The insulin effect plateaus over the next few hours and is followed by a relatively flat. Insulin detemir is an insulin analog coupled to an 18chain. Mechanism of action insulin glargine differs from human insulin by replacing asparagine with glycine in position 21 of the achain and by carboxyterminal extension of bchain by 2 arginine residues. Insulin glargine 21agly30balarg30bblarghuman insulin is a biosynthetic insulin analog with a prolonged duration of action compared with nph human insulin.

Modification of the basic insulin structure has produced a new insulin that is soluble at an acidic ph. This release mechanism allows the drug to mimic basal insulin levels within the body. The concentration of insulin glargine in toujeo is 300 units per ml. Insulin inhibits lipolysis and proteolysis and enhances protein synthesis. There are different types of insulin depending on how quickly they work, when they peak, and how long they last. What are the examples of ligands acting by tyrosine kinases. Research design and methods ten t2dm insulin treated persons were studied during 24h euglycemic glucose clamp, after glargine injection 0. Common side effects include headache, nausea, tiredness, blurred vision, and excessive yawning. Insulin glargine, marketed under the names lantus among others, is a longacting insulin, used in the management of type i and type ii diabetes. The duration of action is slightly longer for glargine than for detemir, although large interindividual differences exist. Slow dissociation from albumin results in longacting properties similar to those of insulin glargine. Pharm, 4th year, 7th semester roll 27701910050 nshm college of.

Highlights of prescribing information carry these highlights. Lantus insulin glargine injection rdna origin is a recombinant human insulin analog indicated for oncedaily subcutaneous administration in the treatment of patients over 17 years of age with type 1. Lixisenatide and insulin glarginelixisenatide briefing document available for public release page 1 of 217 emdac advisory committee meeting. Insulin glargine is a longacting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin therapies are now able to more closely mimic physiologic insulin secretion and. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of carbohydrates, especially glucose from the blood into liver, fat and skeletal muscle cells. Lantus, inninsulin glargine european medicines agency europa. Insulin inhibits lipolysis and proteolysis and enhances protein. It also explains how the signal transduction cascade is affected during type i and type ii diabetes. As with nph insulin, insulin glargine and insulin detemir are used for basal control and should only be administered subcutaneously. Lixisenatide and iglarlixi insulin glarginelixisenatide. Among patients with type 1 diabetes, basal insulins additionally prevent ketogenesis. Pharmacology pharmacodynamics mechanism of action the primary activity of insulin, including insulin glargine. Insulin glargine should not be diluted or mixed with any other insulin or solution.

Insulin glargine is used to improve blood sugar control in people with diabetes mellitus. Insulin glargine is a longacting, recombinant human insulin analog that is given once daily as a basal source of insulin in patients with type 1 or type 2 diabetes mellitus. Design of the novel protraction mechanism of insulin degludec. The pd of insulin glargine differs depending on time of administration.

Insulin and insulin analogs mechanism of action exogenous insulin is administered to replace absent insulin secretion in type1 diabetes or to supplement insufficient insulin secretion in type 2. A metabolism study in humans indicates that insulin glargine is partly metabolized at the carboxyl terminus of the b chain in the subcutaneous depot to form two active metabolites with in vitro activity similar to that of human insulin, m1 21 agly insulin and m2 21 aglydes30 bthr insulin. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Recombinant glargine insulin production process using. Insulin pharmacology, therapeutic regimens, and principles of. Oten insulin glargine containing the indicated percentage of high molecular weight proteins may be prepared by. Types, preparations, drug interactions, dosage, and pregnancy and breastfeeding safety information are provided. Insulin glargine comes as a solution liquid to inject subcutaneously under the skin. Toujeo 300 unitsml is available in a solostar prefilled disposable pen injector. It contains insulin glargine, which is a longacting insulin.

Contains insulin glargine and 0a glargine containing more than 0. Insulin glargine should not be mixed with other insulins, and should only be administered subcutaneously. In clinical pharmacology studies, intravenous insulin glargine and human insulin have been shown to be equipotent when given at the same doses. Patients currently on basal insulin 3060 unitsday with or without a glp1 agonist. Although these mechanisms prolong the absorption kinetics of these products compared. The primary activity of insulin, including insulin glargine, is regulation. Highlights of prescribing information hyperglycemia or. However, glargine pk and plasma cpeptide levels were similar, as well. Insulin glargine has two additional arginine residues two positive charges and one amino acid. A biosimilar version of insulin glargine, developed by wockhardt, is available in india for the treatment of type 1 and type 2 diabetes mellitus. These modifications result in a change of the isoelectric point from a ph of 5.